To investigate whether increased ET-1 signaling via the ETAR could be present in glomerular endothelial cells in FSGS, we collected biopsy samples of patients with FSGS and stained them for ETAR. First, we assessed whether ETAR-positive staining was present in endothelial cells. This evidence concerns the gene EDN1 and focal segmental glomerulosclerosis.